A research study to evaluate the effect of 3 different doses of a new medicine (glycopyrrolate) administered in combination with a licenced medicine (Foster®) in patients with uncontrolled asthma

Registry ID

EUCTR2013-003043-36

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

CHIESI FARMACEUTICI S.p.A

Start date

2014-02-21

Completion date

2015-03-08

Last update

2026-08-16

Conditions

• uncontrolled asthma

Summary

To evaluate the efficacy of a free combination of CHF 5259 (glycopyrrolate bromide [GB]) at 3 dose levels plus Foster 100/6 µg (fixed combination of beclomethasone dipropionate [BDP] plus formoterol [FF]) in a metered dose inhaler by comparison with Foster 100/6 µg in terms of FEV1 AUC0-12h normalised by time on Day 42.

Locations

• , , UK
• , , Bulgarian Drug Agency
• , , Poland
• , , Italy
• , , Germany
• , , Hungary

View on source registry